The Francis Crick Institute
Browse

Protocol for a systematic review to collate the evidence for a relationship between drug levels and treatment outcome in chronic hepatitis B virus (HBV) infection

Download (15.23 kB)
workflow
posted on 2025-03-07, 15:02 authored by Gloria SukaliGloria Sukali, Patricia BiggsPatricia Biggs, Motswedi AndersonMotswedi Anderson, Collins Iwuji, Philippa MatthewsPhilippa Matthews

This protocol sets out an approach for a systematic literature review to collate the evidence for therapeutic drug monitoring of tenofovir and entecavir in the treatment of chronic hepatitis B virus (HBV) infection.

Funding

This work will be taken out with funding support from AHRI-UCL PhD fellowship to GS, and through core funding at the Francis Crick Institute to PCM (ref. CC2223). PCM is also supported by the University College London Biomedical Research Centre (BRC).

HBV Genomics for Elimination Laboratory

Cancer Research UK

Find out more...

History

Usage metrics

    The Francis Crick Institute

    Categories

    Keywords

    Therapeutic drug monitoring (TDM)Drug levelTenofovirEntecavirHBV

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC